Published in Int J Oncol on November 23, 2011
Hypoxia-induced expression of VE-cadherin and filamin B in glioma cell cultures and pseudopalisade structures. J Neurooncol (2013) 0.78
Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts. Oncotarget (2016) 0.75
Perfluorocarbon-Loaded Lipid Nanocapsules to Assess the Dependence of U87-Human Glioblastoma Tumor pO2 on In Vitro Expansion Conditions. PLoS One (2016) 0.75
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer (2008) 18.08
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell (2006) 15.16
A perivascular niche for brain tumor stem cells. Cancer Cell (2007) 11.55
Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res (1999) 10.65
AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood (1997) 7.84
The stem-cell niche as an entity of action. Nature (2006) 7.73
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature (2006) 7.69
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res (2006) 6.77
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature (2008) 5.85
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell (2009) 5.81
Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia (2002) 5.81
A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood (1997) 5.04
Integration of oxygen signaling at the consensus HRE. Sci STKE (2005) 4.95
Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell (2009) 4.82
Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell (2006) 4.20
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle (2009) 3.55
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer (2008) 3.46
Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A (2011) 3.45
A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell (2010) 3.34
Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res (2008) 3.22
Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res (2008) 2.97
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene (2009) 2.86
Cellular mechanism of oxygen sensing. Annu Rev Physiol (2001) 2.84
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest (2008) 2.79
Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res (2004) 2.73
Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. J Biol Chem (2003) 2.36
Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery (2008) 2.33
Identifying cancer stem cells in solid tumors: case not proven. Cancer Res (2006) 2.28
Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol (2001) 2.15
Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell (2009) 2.14
The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res (2010) 2.12
CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev (2009) 2.10
Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res (2010) 2.07
Is tumor growth sustained by rare cancer stem cells or dominant clones? Cancer Res (2008) 1.99
Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci (1999) 1.96
MiR-210--micromanager of the hypoxia pathway. Trends Mol Med (2010) 1.90
Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol (2010) 1.86
Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies. Int J Radiat Oncol Biol Phys (2003) 1.71
Oxygen in the cultivation of stem cells. Ann N Y Acad Sci (2005) 1.69
Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res (2009) 1.69
The role of oxygen in regulating neural stem cells in development and disease. J Cell Physiol (2009) 1.66
Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. EMBO J (2009) 1.66
Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res (2008) 1.51
Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells (2010) 1.40
mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. Cancer Res (2009) 1.36
Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett (2007) 1.34
BMP and FGF regulate the development of EGF-responsive neural progenitor cells. Development (2000) 1.31
Promoter hypomethylation regulates CD133 expression in human gliomas. Cell Res (2008) 1.27
Targeting CD133 antigen in cancer. Expert Opin Ther Targets (2009) 1.26
Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci U S A (1998) 1.24
Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures. Stem Cells Dev (2009) 1.23
Hypoxia and HIF1alpha repress the differentiative effects of BMPs in high-grade glioma. Stem Cells (2009) 1.22
Expression of multidrug resistance genes in normal and cancer stem cells. Cancer Invest (2008) 1.09
Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15. Transl Oncol (2009) 1.06
PO(2) matters in stem cell culture. Cell Stem Cell (2009) 1.02
CD133-positive cells are resistant to TRAIL due to up-regulation of FLIP. Biochem Biophys Res Commun (2008) 0.95
AC133 hematopoietic stem cell antigen: human homologue of mouse kidney prominin or distinct member of a novel protein family? Blood (1998) 0.89
Cancer stem cells: beyond Koch's postulates. Cancer Lett (2008) 0.80
Characterisation of normal and cancer stem cells: one experimental paradigm for two kinds of stem cells. Bioessays (2009) 0.77
Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci (2004) 2.96
New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab (2002) 2.77
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials (2008) 2.43
Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res (2004) 2.34
DNA methylation in glioblastoma: impact on gene expression and clinical outcome. BMC Genomics (2010) 2.32
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial. Lancet Oncol (2013) 2.08
Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials (2006) 1.94
Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy. J Clin Endocrinol Metab (2004) 1.91
The mitochondrial pathways of apoptosis. Adv Exp Med Biol (2012) 1.90
Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members. J Cell Biol (2009) 1.83
Design and production of nanoparticles formulated from nano-emulsion templates-a review. J Control Release (2008) 1.82
Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J Control Release (2006) 1.76
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors. Biomaterials (2009) 1.59
Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics. Clin Chem (2006) 1.55
N6-methyladenine: the other methylated base of DNA. Bioessays (2006) 1.50
Physico-chemical stability of colloidal lipid particles. Biomaterials (2003) 1.44
Active targeting of brain tumors using nanocarriers. Biomaterials (2007) 1.42
Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells. Stem Cells (2006) 1.41
Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett (2007) 1.34
WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol (2009) 1.31
Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma. Hum Mol Genet (2007) 1.27
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol (2010) 1.25
A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res (2002) 1.22
French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol (2007) 1.20
Texture analysis of magnetic resonance images of rat muscles during atrophy and regeneration. Magn Reson Imaging (2005) 1.17
In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification. Mol Cell Proteomics (2010) 1.16
MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes. PLoS One (2011) 1.15
Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. Biomaterials (2006) 1.12
Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine (Lond) (2010) 1.10
Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: in vitro characterization and migration potential in rat brain. Brain Res (2008) 1.08
Adult cell therapy for brain neuronal damages and the role of tissue engineering. Biomaterials (2009) 1.08
A transcriptomic analysis of human centromeric and pericentric sequences in normal and tumor cells. Nucleic Acids Res (2009) 1.07
Undetectable levels of N6-methyl adenine in mouse DNA: Cloning and analysis of PRED28, a gene coding for a putative mammalian DNA adenine methyltransferase. FEBS Lett (2006) 1.06
Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology (Oxford) (2010) 1.06
Perfusional deficit and the dynamics of cerebral edemas in experimental traumatic brain injury using perfusion and diffusion-weighted magnetic resonance imaging. J Neurotrauma (2007) 1.04
Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats. J Neuropathol Exp Neurol (2005) 1.03
PO(2) matters in stem cell culture. Cell Stem Cell (2009) 1.02
The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells. PLoS One (2011) 1.02
Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials (2010) 1.01
Impaired fMRI activation in patients with primary brain tumors. Neuroimage (2010) 1.01
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments. Biomaterials (2007) 1.00
Passive and active tumour targeting with nanocarriers. Curr Drug Discov Technol (2011) 1.00
A putative generalized model of the effects and mechanism of action of high frequency electrical stimulation of the central nervous system. Acta Neurol Belg (2005) 1.00
A 4-gene signature associated with clinical outcome in high-grade gliomas. Clin Cancer Res (2011) 0.99
A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations. Pharm Res (2002) 0.99
Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion. Int J Pharm (2007) 0.98
Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons. Bone (2006) 0.98
Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3. J Bone Miner Res (2004) 0.98
Development of gliomas: potential role of asymmetrical cell division of neural stem cells. Lancet Oncol (2004) 0.96
Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line. FEBS Lett (2007) 0.96
A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther (2006) 0.95
A review of the current status of siRNA nanomedicines in the treatment of cancer. Biomaterials (2013) 0.95
Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse. Mol Vis (2005) 0.95
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients. Mol Cancer (2010) 0.95
SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas. PLoS One (2012) 0.94
Infection of human astrocytes and glioblastoma cells with Toxoplasma gondii: monocyte chemotactic protein-1 secretion and chemokine expression in vitro. Acta Neuropathol (2004) 0.93
The extracellular matrix glycoprotein Tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor. Eur J Neurosci (2004) 0.92
Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel. Eur J Pharm Biopharm (2009) 0.92
The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy. Biomaterials (2010) 0.92
Implanted carmustine wafers followed by concomitant radiochemotherapy to treat newly diagnosed malignant gliomas: prospective, observational, multicenter study on 92 cases. Ann Surg Oncol (2012) 0.91
Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models. Nanomedicine (2012) 0.90
Tumor transfection after systemic injection of DNA lipid nanocapsules. Biomaterials (2010) 0.90
Brain targeting using novel lipid nanovectors. J Control Release (2007) 0.90
Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres. Eur J Pharm Biopharm (2002) 0.90
Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres. Eur J Pharm Biopharm (2008) 0.90
The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Biomaterials (2010) 0.90
Repair of avulsed ventral nerve roots by direct ventral intraspinal implantation after brachial plexus injury. Hand Clin (2005) 0.90
Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes. J Control Release (2004) 0.89
The encapsulation of DNA molecules within biomimetic lipid nanocapsules. Biomaterials (2009) 0.89
In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy. J Neurooncol (2009) 0.89
Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial. Neurosurgery (2005) 0.89
Isolation of a new cell population in the glioblastoma microenvironment. J Neurooncol (2011) 0.88
Dietary prevention of malignant glioma aggressiveness, implications in oxidant stress and apoptosis. Int J Cancer (2008) 0.88
Drug delivery into the brain using poly(lactide-co-glycolide) microspheres. Expert Opin Drug Deliv (2005) 0.88
Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells. Pharm Res (2011) 0.88
New lipid nanocapsules exhibit sustained release properties for amiodarone. J Control Release (2002) 0.88
Actuality of Warburg's views in our understanding of renal cancer metabolism. J Bioenerg Biomembr (2007) 0.87
Functional expression of V-ATPases in the plasma membrane of glial cells. Glia (2002) 0.87
Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice. Pharm Res (2010) 0.87
Immune genes are associated with human glioblastoma pathology and patient survival. BMC Med Genomics (2012) 0.87
Assessment of myocardial viability in rats: Evaluation of a new method using superparamagnetic iron oxide nanoparticles and Gd-DOTA at high magnetic field. Magn Reson Med (2004) 0.87
Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials (2011) 0.87
Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface. Electrophoresis (2005) 0.86